Goals:
The pharmacy of the CESAME, a psychiatric hospital in France, bought an automatic dispensing machine (ADM) to implement drug safety management. A risk mapping was set up prior to its launching to secure the new process.
This study aims to update this mapping based on notified adverse events (NAE) during the first ten months of production. Method: -Retroactive analysis of NAE: events classification, computation of observed frequencies. -Risk defined prior to the study: risk rating update based on frequency. -Undefined risk: risk introduction with its scoring.
-The risk-rate is computed with the combination of two parameters: frequency and severity. It results in a criticality indexed on a scale from 1 to 16. Results: -1 new stage of risk identified and scored in the field of software parameterization,
-Rise in criticality of 4 risks: 2 concerning the production, 1 concerning the unpackaging and 1 the visual control of production, -Pharmacy is responsible for 54 % of NAE, 87 % of those are linked to a failure at the stage of visual control of production by the pharmacy technician. Discussion & Conclusion: This study has allowed us to deepen our understanding of the process' weaknesses thus helping to identify the needs of corrective measures.
For example, controlling stage is ranked 16. We set up urgent measures aiming to mimize distractions in the production area (new space organization by partitioning locals and the removal of the phone) and a review of the procedure "Implementation of automatic individual dose preparation" with the team. Furthermore, a flowchart called "new drug automatisation" has been created and a monthly description-drug verification has been established.
As 46 % of NAE are not imputed to automation, this work also showed the necessity of emphasizing our communication to nurses on the scope of action and limits of automated individual dose dispensing 
